Candriam SCA’s Madrigal Pharmaceuticals MDGL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$44.5M	Buy	84,948 +21,042	+33%	+$10.1M	0.23%	97
2025 Q4	$37.2M	Buy	63,906 +13,941	+28%	+$7.12M	0.19%	124
2025 Q3	$22.9M	Hold	49,965	–	–	0.12%	164
2025 Q2	$15.1M	Buy	49,965 +28,593	+134%	+$8.52M	0.09%	199
2025 Q1	$7.08M	Buy	+21,372	New	+$7.02M	0.04%	275
2024 Q2	–	Sell	-18,000	Closed	-$4.81M	–	711
2024 Q1	$4.81M	Sell	18,000 -9,000	-33%	-$2.12M	0.03%	350
2023 Q4	$6.25M	Sell	27,000 -2,000	-7%	-$350K	0.04%	309
2023 Q3	$4.24M	Hold	29,000	–	–	0.03%	326
2023 Q2	$6.7M	Buy	+29,000	New	+$7.85M	0.05%	296
2021 Q2	–	Sell	-31,722	Closed	-$3.39M	–	924
2021 Q1	$3.39M	Hold	31,722	–	–	0.03%	437
2020 Q4	$3.53M	Sell	31,722 -62,862	-66%	-$7.68M	0.03%	448
2020 Q3	$11.2M	Sell	94,584 -8,000	-8%	-$869K	0.11%	211
2020 Q2	$11.6M	Buy	102,584 +61,634	+151%	+$6.06M	0.12%	195
2020 Q1	$3.65M	Hold	40,950	–	–	0.04%	423
2019 Q4	$3.73M	Sell	40,950 -500	-1%	-$48.5K	0.04%	437
2019 Q3	$3.57M	Hold	41,450	–	–	0.05%	386
2019 Q2	$4.33M	Hold	41,450	–	–	0.05%	363
2019 Q1	$5.19M	Buy	41,450 +10,000	+32%	+$1.24M	0.07%	315
2018 Q4	$3.54M	Buy	31,450 +17,500	+125%	+$2.71M	0.05%	347
2018 Q3	$2.99M	Buy	13,950 +4,550	+48%	+$1.14M	0.04%	416
2018 Q2	$2.63M	Buy	+9,400	New	+$1.65M	0.04%	426